🔥🐔 BizChicken 🐔🔥
Companies Similar to AEON Biopharma, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
ABVC BioPharma, Inc.
ABV-1501, ABV-1504, ABV-1505, ABV-1703, ABV-1702, ABV-1601, ABV-1701 Vitargus
ABVC Bio Pharma, Inc., based in Fremont, California, is a clinical stage biopharmaceutical company developing drugs and medical devices to address unmet medical needs in the United States. The company is involved in developing therapies for conditions such as cancer, major depressive disorders, and attention deficit hyperactivity disorder.
Symbol: ABVC
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Uttam Yashwant Patil Ph.D.
Sector: Healthcare
Employees: 16
Address: 44370 Old Warm Springs Boulevard, Fremont, CA 94538
Phone: 510 668 0881
Last updated: 2024-12-31
AEON Biopharma, Inc.
ABP-450
AEON Biopharma, Inc. is a biopharmaceutical company focused on developing botulinum toxins for treating debilitating medical conditions. The company also develops ABP-450 for migraines, cervical dystonia, and gastroparesis.
Symbol: AEON
Recent Price: $0.56
Industry: Biotechnology
CEO: Mr. Marc Forth
Sector: Healthcare
Employees: 5
Address: 4040 Macarthur Boulevard, Newport Beach, CA 92614
Phone: 949-354-6499
Last updated: 2024-12-31
Absci Corporation
Integrated Drug Creation Platform
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using an integrated drug creation platform for partners in the United States. Its platform enables the creation of biologics by unifying the drug discovery and cell line development processes.
About | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: ABSI
Recent Price: $2.65
Industry: Biotechnology
CEO: Mr. Sean McClain
Sector: Healthcare
Employees: 155
Address: 18105 SE Mill Plain Boulevard, Vancouver, WA 98683
Phone: 360 949 1041
Last updated: 2024-12-31
Amylyx Pharmaceuticals, Inc.
AMX0035
Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Their leading product, AMX0035, is aimed at ALS treatment.
About | Leadership | Directors | Contact | Careers | About | About | About | About | About | About | About | About | News | About
Symbol: AMLX
Recent Price: $3.84
Industry: Biotechnology
CEO: Mr. Joshua B. Cohen
Sector: Healthcare
Employees: 384
Address: 43 Thorndike Street, Cambridge, MA 02141
Phone: 617 682 0917
Leadership
- Linda A. Arsenault, Chief Human Resources Officer
- Camille L. Bedrosian, MD, Chief Medical Officer
- Josh Cohen, Co-CEO & Co-Founder
- James M. Frates, Chief Financial Officer
- Tom Holmes, Chief Technical Operations Officer
- Justin Klee, Co-CEO & Co-Founder
- Gina M. Mazzariello, Chief Legal Officer & General Counsel
- Rudolph Tanzi, PhD, Founding Chair of the Amylyx SAB
- Wally Gilbert, Special Advisor
- Kari Firestone, Director
- Paul Fonteyne, Director
- George Milne, Chairman
- Daphne Quimi, Director
- Bernhardt G. Zeiher, MD, FACP, FCCP, Director
Last updated: 2024-12-31
Anebulo Pharmaceuticals, Inc.
ANEB-001
Anebulo Pharmaceuticals is a clinical-stage biotechnology company focused on developing and commercializing treatments for acute cannabinoid intoxication and substance addiction, including their lead product candidate ANEB-001.
Symbol: ANEB
Recent Price: $1.64
Industry: Biotechnology
CEO: Mr. Richard Anthony Cunningham
Sector: Healthcare
Employees: 2
Address: 1415 Ranch Road 620 South, Lakeway, TX 78734
Phone: 512 598 0931
Last updated: 2024-12-31
Annexon, Inc.
ANX005
Annexon, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. It develops several investigational monoclonal antibodies targeting distinct disease processes.
Symbol: ANNX
Recent Price: $5.13
Industry: Biotechnology
CEO: Mr. Douglas Love Esq., J.D.
Sector: Healthcare
Employees: 71
Address: 1400 Sierra Point Parkway, Brisbane, CA 94005
Phone: 650 822 5500
Last updated: 2024-12-31
Apollomics, Inc.
APL-101 (Vebreltinib), APL-102, APL-122
Apollomics, Inc. is a biotechnology company that discovers and develops oncology therapies to address unmet medical needs, focusing on treatments for non-small cell lung cancer, liver cancer, breast cancer, esophageal cancer, and brain tumors.
Symbol: APLM
Recent Price: $10.13
Industry: Biotechnology
CEO: Dr. Guo-Liang Yu Ph.D.
Sector: Healthcare
Employees: 45
Address: 989 East Hillsdale Blvd, Foster City, CA 94404
Phone: 650 209 4055
Last updated: 2024-12-31
Ardelyx, Inc.
tenapanor
Ardelyx, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for gastrointestinal and cardiorenal therapeutic areas, including treatments for irritable bowel syndrome with constipation and hyperphosphatemia.
About | Vision/Values | Leadership | About | About | About | About | Contact | About | About | About
Symbol: ARDX
Recent Price: $5.25
Industry: Biotechnology
CEO: Mr. Michael G. Raab
Sector: Healthcare
Employees: 267
Address: 400 Fifth Avenue, Waltham, MA 02451
Phone: 510 745 1700
Leadership
- Justin Renz, Chief Financial & Operations Officer
- Eric Foster, Chief Commercial Officer
- Elizabeth Grammer, Esq., Chief Legal & Administrative Officer
- Laura Williams, MD MPH, Chief Medical Officer
- Robert Blanks, MS RAC, Chief Regulatory Affairs & Quality Assurance Officer
- David Rosenbaum, PhD, Chief Development Officer
- Mike Kelliher, Executive Vice President, Corporate Development and Strategy
- Charon Spencer, Chief Human Resources Officer
- David Mott, Chairman
- Robert Bazemore, Director
- William A. Bertrand, Jr., JD, Director
- Muna Bhanji, R.Ph, Director
- Onaiza Cadoret-Manier, Director
- Mike Raab, Director
- Richard Rodgers, Director
Last updated: 2024-12-31
Aura Biosciences, Inc.
AU-011
Aura Biosciences, Inc. operates as a biotechnology company developing virus-like drug conjugates (VDC) platform for treating ocular and urologic oncology tumors, with a focus on AU-011 for choroidal melanoma.
About | About | Management | Directors | About | Contact | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: AURA
Recent Price: $8.13
Industry: Biotechnology
CEO: Dr. Elisabet de los Pinos Ph.D.
Sector: Healthcare
Employees: 88
Address: 85 Bolton Street, Cambridge, MA 02140
Phone: 617 500 8864
Leadership
- David Johnson, Chairman
- Elisabet de los Pinos, PhD, Chief Executive Officer
- Giovanni Mariggi, PhD, Director
- Antony Mattessich, Director
- Sapna Srivastava, PhD, Director
- Karan Takhar, Director
Last updated: 2024-12-31
Anavex Life Sciences Corp.
ANAVEX 2-73
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.
Symbol: AVXL
Recent Price: $11.04
Industry: Biotechnology
CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
Sector: Healthcare
Employees: 40
Address: 51 West 52nd Street, New York, NY 10019
Phone: 844 689 3939
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
iTeos Therapeutics, Inc.
inupadenant, EOS-448
Iteos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of immuno-oncology therapeutics. Their product pipeline includes inupadenant and EOS-448, which are in various phases of clinical trials.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About | About | About | About
Symbol: ITOS
Recent Price: $7.29
Industry: Biotechnology
CEO: Dr. Michel Detheux Ph.D.
Sector: Healthcare
Employees: 157
Address: 321 Arsenal Street, Cambridge, MA 02472-5710
Phone: 339 217 0161
Leadership
- Michel DETHEUX, President, Chief Executive Officer
- Matt CALL, Chief Operating Officer
- Matthew GALL, Chief Financial Officer
- Yvonne MCGRATH, Chief Scientific Officer
- David Feltquate, Chief Medical Officer
- Philippe BRANTEGEM, Executive Vice President of Human Resources
- Adi OSOVSKY, Executive Vice President of Legal
- David HALLAL, Chair of the Board
- Aaron DAVIS,
- Jill DESIMONE,
- David LEE,
- Tim VAN HAUWERMEIREN,
- Tony HO,
- Robert IANNONE,
- Ann RHOADS,
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Revance Therapeutics, Inc.
Daxibotulinumtoxin A
Revance Therapeutics, Inc. is a biotechnology company focused on developing, manufacturing, and commercializing neuromodulators for various aesthetic and therapeutic indications.
Leadership | About | About | Contact | Contact | About | About | About | Careers | Culture | Benefits | Directors | About | Sustainability | About | News | Events | About | About | About | About
Symbol: RVNC
Recent Price: $3.06
Industry: Biotechnology
CEO: Mr. Mark J. Foley
Sector: Healthcare
Employees: 597
Address: 1222 Demonbreun Street, Nashville, TN 37203
Phone: 615 724 7755
Leadership
- Mark J. Foley, Chief Executive Officer
- Tobin Schilke, Chief Financial Officer
- Erica Jordan, Chief Commercial Officer
- Dwight O. Moxie, Chief Legal Officer and General Counsel
- Amie Krause, Chief People Officer
- David A. Hollander, Chief Medical Officer, Global Therapeutics Franchise Lead
- Angus C. Russell, CHAIRMAN OF THE BOARD, CHAIR, NOMINATING AND GOVERNANCE COMMITTEE
- Chris Nolet, Chair, Audit Committee
- Jill Beraud, CHAIR, BRAND COMMITTEE, COMPENSATION COMMITTEE
- Vlad Coric,
- Julian S. Gangolli,
- Carey O’Connor Kolaja,
- Olivia C. Ware,
Last updated: 2024-12-31
Synaptogenix, Inc.
Bryostatin-1
Synaptogenix, Inc. is a biopharmaceutical company focused on developing drug candidates for neurodegenerative diseases, including Alzheimer's disease, using Bryostatin-1.
Symbol: SNPX
Recent Price: $3.37
Industry: Biotechnology
CEO: Dr. Alan J. Tuchman M.D., MBA(FAAN)
Sector: Healthcare
Employees: 5
Address: 1185 Avenue of the Americas, New York, NY 10036
Phone: 973 242 0005
Last updated: 2024-12-31
Titan Pharmaceuticals, Inc.
Pro Neura
Titan Pharmaceuticals, Inc. is a pharmaceutical company developing therapeutics for chronic diseases utilizing the Pro Neura drug delivery platform. Its products include the Probuphine implant for opioid use disorder treatment, among other programs for chronic pruritus, opioid relapse prevention, HIV prevention, and contraception.
About | About | Leadership | Directors | About | Contact | Directors | Directors | Directors | Careers | About
Symbol: TTNP
Recent Price: $3.40
Industry: Biotechnology
CEO: Jennifer Kiernan
Sector: Healthcare
Employees: 4
Address: 400 Oyster Point Boulevard, South San Francisco, CA 94080-1958
Phone: 650 244 4990
Leadership
- Dato’ Seow Gim Shen, Chief Executive Officer and Chairman of the Board of Directors
- Avraham Ben-Tzvi, Founder
- Brynner Chiam, Vice President of Finance and Tax
- Firdauz Edmin Bin Mokhtar, Chief Executive Officer
- Francisco Osvaldo Flores García, Managing Partner
Last updated: 2024-12-31
Annovis Bio, Inc.
Buntanetap
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound, Buntanetap, is in clinical trials for various neurodegenerative disorders.
Symbol: ANVS
Recent Price: $5.08
Industry: Biotechnology
CEO: Dr. Maria L. Maccecchini Ph.D.
Sector: Healthcare
Employees: 6
Address: 1055 Westlakes Drive, Berwyn, PA 19312
Phone: 610 727 3913
Last updated: 2024-12-31
AN2 Therapeutics, Inc.
epetraborole
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases, including epetraborole for non-tuberculous mycobacterial lung disease.
About | About | Contact | Contact | Careers | Careers | Careers | About | Vision/Values | Jobs | Vision/Values | Benefits | Jobs | Benefits
Symbol: ANTX
Recent Price: $1.41
Industry: Biotechnology
CEO: Mr. Eric E. Easom
Sector: Healthcare
Employees: 41
Address: 1800 El Camino Real, Menlo Park, CA 94027
Phone: 650-331-9090
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
Arbutus Biopharma Corporation
AB-729, AB-836, AB-161, AB-101
Arbutus Biopharma Corporation is a biopharmaceutical company that develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses. The company's HBV product pipeline includes RNA interference products and oral capsid inhibitors, and it is involved in strategic alliances for research and development.
About | Leadership | Directors | Contact | Contact | Culture | Jobs | Culture | About | About
Symbol: ABUS
Recent Price: $3.20
Industry: Biotechnology
CEO: Mr. Michael J. McElhaugh
Sector: Healthcare
Employees: 73
Address: 701 Veterans Circle, Warminster, PA 18974
Phone: 267 469 0914
Leadership
- Michael J. McElhaugh, Interim President and Chief Executive Officer and Director
- Michael J. Sofia PhD, Chief Scientific Officer
- Karen Sims, MD, PhD, Chief Medical Officer
- David C. Hastings, Chief Financial Officer
- Christopher Naftzger, General Counsel and Chief Compliance Officer
- Lisa Caperelli, Vice President, Investor Relations
- Shannon Briscoe, SPHR, SHRM-SCP, Vice President, Human Resources
- Frank Torti, MD, Chairman
- Daniel Burgess, Independent Director
- Richard C. Henriques, Independent Director
- Keith Manchester, MD, Independent Director
- James Meyers, Independent Director
- Melissa V. Rewolinski, PhD, Independent Director
Last updated: 2024-12-31